Biotechnology Stocks I Performance Guide: ImmunityBio, Inc. (IBRX)
IBRX has no dividends
Table and Chart of IBRX Performance
See what a $1,000 investment in IBRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IBRX Returns | |
|---|---|
| Start Date | Aug-31-2015 |
| Start Price | $17.12 |
| End Date | Dec-01-2023 |
| End Price | $3.78 |
| # Prices | 101 |
| Min Date | Jun-28-2019 |
| Min Price | $1.02 |
| Max Date | Feb-26-2021 |
| Max Price | $32.51 |
| Total Return | -77.92% |
| Annualized Return | -16.43% |
| Current Value of $1,000 Purchase | $221 |
| Number Returns | 5,050 |
| Average Return | 65.69% |
| Number Profitable Returns | 2,012 |
| Percent Profitable Returns | 39.84% |
| Number Unprofitable Returns | 3,038 |
| Percent Unprofitable Returns | 60.16% |
| Profitable to Unprofitable Returns Ratio | 0.66 |
| IBRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,523,925,000 | Price to Sales | 4,539.43 |
| Earnings per Share | $-1.0400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $7.1 |
| 52 Week Low | $1.21 |
| Analyst Target Price | $4.5 |
| 50-Day Moving Average | $2.571 |
| 200-Day Moving Average | $2.406 |
| FINANCIAL DATA | |
| Revenue per Share | $0.001 |
| Revenue | $556,000 |
| Profit Margin | 0% |
| Return on Equity | 0% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IBRX Compare Returns with S&P 500
IBRX Trendline Chart